Search - tctmd.com

Displaying 161 - 180 of 180

Sort: Relevancy | Date

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Industry News

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

March 06, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Industry News

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

October 13, 2015

News Industry News

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

October 07, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Industry News

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

June 23, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

News Daily News

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Caitlin E. Cox

May 29, 2015

News Conference News EuroPCR 2015

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Yael L. Maxwell

May 22, 2015

News Conference News ACC 2015

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Yael L. Maxwell

March 15, 2015

News Daily News

PARTNER Subanalysis Examines Effect of Annulus Size on Valve Hemodynamics, Outcomes

Yael L. Maxwell

October 10, 2014

News Daily News

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

July 03, 2014

News Conference News ACC 2014

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Yael L. Maxwell

March 29, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

L.A. McKeown

July 24, 2013

Advertisement

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

PARTNER Subanalysis Examines Effect of Annulus Size on Valve Hemodynamics, Outcomes

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

TAVR With the CoreValve Device Superior to Surgery at 1 Year

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

Medtronic CoreValve® System Obtains Early FDA Approval

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content